Table S2 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Authors :: Federico Innocenti
Kari K. Alitalo
Nancy Klauber-DeMore
Yuri K. Peterson
Carol E. Peña
Eleanor Hilliard
Amy S. Etheridge
Dylan M. Glubb
Veli-Matti Leppänen
Andrew D. Skol
Daniel J. Crona
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Bioinformatic analyses.

Full Text Access

Tools